ID   Tu 138
AC   CVCL_4910
SY   Tu-138; Tu138
DR   BioSample; SAMN03151956
DR   Wikidata; Q54973307
RX   PubMed=8033080;
RX   PubMed=21868764;
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764). Originally thought to originate from a gingivo-labial moderately differentiated squamous carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00428.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
RX   PubMed=8033080;
RA   Liu T.-J., Zhang W.-W., Taylor D.L., Roth J.A., Goepfert H.,
RA   Clayman G.L.;
RT   "Growth suppression of human head and neck cancer cells by the
RT   introduction of a wild-type p53 gene via a recombinant adenovirus.";
RL   Cancer Res. 54:3662-3667(1994).
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).